Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 11
|
pp. 10074–10107
Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3
Back to article
Figure 2
(2 of 6)
−
100%
+
Figure 2.
KM survival curves based on overall survival in 7 cancers.
(
A
) COAD; (
B
) HNSC; (
C
) KIRC; (
D
) LUAD; (
E
) THCA; (
F
) UCFC; (
G
) UVM.
